Literature DB >> 16054715

Effects of statins beyond lipid lowering: potential for clinical benefits.

Khalid Almuti1, Rola Rimawi, Daniel Spevack, Robert J Ostfeld.   

Abstract

BACKGROUND: The role of statin drugs in the reduction of serum lipids has been well documented. More recently, evidence suggesting that statins may positively impact many organ systems and disease states independent of lipid reduction has emerged. The term "pleiotropic effects" has been used to refer to these properties. We reviewed the evidence exploring such potential effects.
METHODS: A search of the MEDLINE database was conducted for articles published between 1985 to 2005 on the pleiotropic and the lipid-lowering independent effects of statin drugs. The search terms "statin", "HMG-CoA reductase inhibitor", "pleiotropic effects", and "inflammation" were used. English language articles were selected for inclusion along with selected cross-references.
RESULTS: Numerous animal and clinical studies support the presence of a spectrum of beneficial effects for statins that are independent of their lipid-lowering properties. These effects are mediated by a variety of mechanisms and they suggest that the therapeutic role of statins may expand.
CONCLUSION: Statins have shown great promise beyond their lipid-lowering effects. Ongoing and future studies will help to further clarify the potential clinical impact of these "pleiotropic effects".

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054715     DOI: 10.1016/j.ijcard.2005.05.056

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  35 in total

1.  Theoretical study of hydrogen bond interactions of fluvastatin with ι-carrageenan and λ-carrageenan.

Authors:  Anastasios G Papadopoulos; Michael P Sigalas
Journal:  J Mol Model       Date:  2010-10-28       Impact factor: 1.810

2.  Association between statin use and second cancer risk in breast cancer patients: a nationwide population-based cohort study.

Authors:  Yin-Che Lu; Da-Wei Huang; Pin-Tzu Chen; Ching-Fang Tsai; Mei-Chen Lin; Che-Chen Lin; Shi-Heng Wang; Yi-Jiun Pan
Journal:  Breast Cancer Res Treat       Date:  2020-10-16       Impact factor: 4.872

Review 3.  Statin and Atrial Fibrilation: When does it work?

Authors:  Laurent Fauchier; Nicolas Clementy; Bertrand Pierre; Dominique Babuty
Journal:  J Atr Fibrillation       Date:  2012-08-20

Review 4.  Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research.

Authors:  Amir A Zeki; Nicholas J Kenyon; Tzipora Goldkorn
Journal:  Drug Metab Lett       Date:  2011-01

5.  Protective role of atorvastatin against doxorubicin-induced cardiotoxicity and testicular toxicity in mice.

Authors:  S V V S Ramanjaneyulu; P P Trivedi; S Kushwaha; A Vikram; G B Jena
Journal:  J Physiol Biochem       Date:  2013-02-06       Impact factor: 4.158

6.  Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond.

Authors:  Amir A Zeki; Lisa Franzi; Jerold Last; Nicholas J Kenyon
Journal:  Am J Respir Crit Care Med       Date:  2009-07-16       Impact factor: 21.405

7.  Statins cause profound effects on gene expression in human cancer cells in vitro: the role of membrane microdomains.

Authors:  David John Garnett; Trevor James Greenhough
Journal:  Gene Expr       Date:  2012

8.  Arterial inflammation in bronchial asthma.

Authors:  Jayanthi Vijayakumar; Sharath Subramanian; Parmanand Singh; Erin Corsini; Sara Fontanez; Meredith Lawler; Rebecca Kaplan; Thomas J Brady; Udo Hoffmann; Ahmed Tawakol
Journal:  J Nucl Cardiol       Date:  2013-03-23       Impact factor: 5.952

9.  Effect of preoperative statin therapy on myocardial protection and morbidity endpoints following off-pump coronary bypass surgery in patients with elevated C-reactive protein level.

Authors:  Young Song; Young Lan Kwak; Yong Seon Choi; Jong Chan Kim; Sang Baek Heo; Jae Kwang Shim
Journal:  Korean J Anesthesiol       Date:  2010-02-28

10.  Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders.

Authors:  Anjana Yadav; Michael R Betts; Ronald G Collman
Journal:  J Neurovirol       Date:  2016-03-28       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.